Back to search

Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer

Data up to Jan 2025

Published2004
Citations62
References84

Total Citations Per Year

Abstract

References (84)

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

2002 • 18,132 citations

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 8,631 citations

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

1998 • 7,971 citations

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

2002 • 6,780 citations

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

1998 • 5,293 citations

Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance

2003 • 2,035 citations

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

1998 • 1,728 citations

Insulin-like growth factors and neoplasia

2004 • 1,452 citations

Pathophysiology of insulin resistance in human disease

1995 • 1,239 citations

Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome

2003 • 869 citations

Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study

2002 • 859 citations

The Insulin-Related Ovarian Regulatory System in Health and Disease

1999 • 797 citations

Weight Loss in Breast Cancer Patient Management

2002 • 604 citations

PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance

2003 • 600 citations

The statins as anticancer agents.

2003 • 595 citations

Genetic cause of hyperglycaemia and response to treatment in diabetes

2003 • 583 citations

Insulin Resistance as a Predictor of Age-Related Diseases

2001 • 579 citations

Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity

2004 • 570 citations

Adiponectin and Breast Cancer Risk

2004 • 534 citations

The Risk of Cancer in Users of Statins

2004 • 514 citations

Pharmacogenetic Study of Statin Therapy and Cholesterol Reduction

2004 • 455 citations

Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted?

2000 • 449 citations

Risk Factors for Advanced Colonic Neoplasia and Hyperplastic Polyps in Asymptomatic Individuals

2003 • 436 citations

Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists

2004 • 433 citations

A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men

2004 • 333 citations

Metformin

2003 • 314 citations

Leptin Enhances, via AP-1, Expression of Aromatase in the MCF-7 Cell Line

2003 • 281 citations

Cholesterol and prostate cancer

2003 • 266 citations

Reducing insulin resistance with metformin: the evidence today

2003 • 257 citations

Safety and Tolerability of Pravastatin in Long-Term Clinical Trials

2002 • 241 citations

Statin Therapy, Cardiovascular Events, and Total Mortality in the Heart and Estrogen/Progestin Replacement Study (HERS)

2002 • 234 citations

Use of the Peroxisome Proliferator-Activated Receptor (PPAR) γ Ligand Troglitazone as Treatment for Refractory Breast Cancer: A Phase II Study

2003 • 230 citations

Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy

2003 • 228 citations

Weight Loss in Breast Cancer Patient Management

2002 • 227 citations

Metabolic Effects of Rosiglitazone in HIV Lipodystrophy

2004 • 215 citations

Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.

2000 • 191 citations

Potential antitumor effects of statins (Review)

2003 • 191 citations

The Insulin-Related Ovarian Regulatory System in Health and Disease

1999 • 189 citations

Risk of endometrial and breast cancer in patients with diabetes mellitus

1997 • 188 citations

The nicotinic acid receptor–a new mechanism for an old drug

2004 • 187 citations

Abnormal Glucose Tolerance and the Risk of Cancer Death in the United States

2003 • 182 citations

Membrane fluidity in malignancy Adversative and recuperative

1984 • 167 citations

A phase II trial with rosiglitazone in liposarcoma patients

2003 • 161 citations

An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress

2003 • 159 citations

Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells

2003 • 152 citations

Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study

2003 • 147 citations

Serum Cholesterol and Cancer Risk: An Epidemiologic Perspective

1992 • 147 citations

Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome

2004 • 142 citations

A Ligand of Peroxisome Proliferator-Activated Receptor gamma, Retinoids, and Prevention of Preneoplastic Mammary Lesions

2000 • 142 citations

Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

1985 • 129 citations

Insulin Resistance as a Predictor of Age-Related Diseases

2001 • 128 citations

Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells

2003 • 120 citations

The association between 3‐hydroxy‐3‐methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women

2004 • 115 citations

Importance of Adipocytokines in Obesity-Related Diseases

2003 • 114 citations

The metabolic syndrome in long-term cancer survivors, and important target for secondary preventive measures

2002 • 111 citations

Insulin and longevity: antidiabetic biguanides as geroprotectors.

2003 • 95 citations

Birth weight and risk of early-onset breast cancer (Denmark).

2003 • 93 citations

Statin use and the risk of breast cancer

2003 • 92 citations

Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X

2000 • 87 citations

HMG CoA reductase inhibitors and the risk of colorectal cancer

2004 • 81 citations

Proposed Treatment of Cancer by Inhibition of Gluconeogenesis

1968 • 80 citations

Niacin and Carcinogenesis

2003 • 78 citations

Development, aging, and disease : a new rationale for an intervention strategy

1994 • 75 citations

Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent

2003 • 72 citations

Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C‐reactive protein in subjects with impaired fasting glucose

2003 • 63 citations

Metabolomics Takes Its Place as Latest Up-and-Coming "Omic" Science

2004 • 63 citations

Effects of phenformin on the proliferation of human tumor cell lines

2003 • 45 citations

law of deviation of homeostasis and diseases of aging

1981 • 45 citations

Treatment of PCOS with metformin and other insulin-sensitizing agents

2004 • 43 citations

Does Lowering Cholesterol Cause Cancer?

1996 • 43 citations

Carcinogenicity of lipid-lowering drugs

1996 • 43 citations

Melanoma Chemoprevention: A Role for Statins or Fibrates?

2003 • 40 citations

Preliminary evidence on metabolic rehabilitation of cancer patients.

1988 • 35 citations

Newborn Macrosomy And Cancer

1988 • 32 citations

Metabolic Immunodepression and Metabolic Immunotherapy

1982 • 32 citations

Molecular Regulation of Cholesterol Biosynthesis: Implications in Carcinogenesis

2003 • 29 citations

Hypolipidemic therapy and cholesterol absorption

2004 • 22 citations

Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new disease

2003 • 19 citations

[Cholesterolemia and total, cardiovascular and cancer mortality. Study of a cohort of 220,000 people].

1998 • 11 citations

Does lowering cholesterol cause cancer?

1996 • 5 citations

Cancer proneness profile. A study in ponderal index and blood glucose.

1969 • 5 citations

Studies on the antitumoral activity of the biguanides. V.

1967 • 2 citations

Effects of Misclerone (Clofibrate) on Dimethylhydrazine-Induced Intestinal Carcinogenesis in Rats

1982 • 2 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...